Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-03-21Clinical Trial Update: The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome
Clinical trial update examining the roles of TCF7L2 and SLC30A8 in antipsychotic-induced metabolic syndrome in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Study Evaluating Vabicaserin in Subjects With Schizophrenia [Phase 2]
Pfizer completed a Phase 2 clinical trial evaluating vabicaserin in schizophrenia, with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-03-19Clinical Trial Update: Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia
This completed clinical trial evaluates the validation of a scale intended to predict relapse and short-term rehospitalization in patients w…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia [Phase 2]
Phase 2 pharmacokinetics study evaluating safety and tolerability of JNJ-37822681 in adults with stable schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Health Promotion and Fitness for Younger and Older Adults With SMI [NA]
A completed clinical trial update evaluating health promotion and fitness interventions for younger and older adults with serious mental ill…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg [Phase 1]
A Phase 1 pharmacokinetic comparison of DWCZP 100 mg and Clozaril (clozapine) 100 mg in schizophrenia has been completed and results are pos…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Effects of Antipsychotic Medications on Energy Intake and Expenditure
A completed clinical trial evaluated the effects of antipsychotic medications on energy intake and energy expenditure in people with schizop…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Janssen - Glucose Regulation/Risp/Olanz [NA]
A Janssen-sponsored study evaluating glucose regulation in schizophrenia patients treated with risperidone or olanzapine has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Pfizer/IVGTT/Ziprasidone/Olanzapine [NA]
This clinical trial update reports completion of a study involving ziprasidone and olanzapine in schizophrenia and type 2 diabetes mellitus.…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]
This Phase 4 trial evaluated the efficacy and safety of long-acting injectable risperidone compared with oral risperidone in adults with sch…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia [Phase 1, Phase 2]
Clinical trial update reporting results from Phase 1 and Phase 2 evaluating targeted cognitive training for neurological deficits in people …
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Paliperidone Palmitate Flexible Dosing in Schizophrenia [Phase 3]
A Phase 3 study evaluating flexible dosing of paliperidone palmitate for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants [Phase 4]
Phase 4 study assessing paliperidone extended-release for schizophrenia has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia [Phase 4]
This Phase 4 clinical trial reports on different Paliperidone Extended-Release dosing regimens and the clinical response in adults with acut…
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER [Phase 4]
A Phase 4 study assessing early prediction of clinical response to paliperidone ER in patients with schizophrenia (and schizoaffective disor…
-
FDA approval · 2014-02-28FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc., resulting in an ap…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment [Phase 4]
Phase 4 study evaluating the efficacy and safety of long-acting risperidone in adults with schizophrenia or schizoaffective disorder receivi…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Cognitive Remediation Therapy and Schizophrenia [NA]
A completed clinical trial evaluating cognitive remediation therapy for schizophrenia.
-
FDA approval · 2014-02-18FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism- [Phase 4]
Phase 4 clinical trial evaluating the effects of aripiprazole on glucose metabolism in patients with schizophrenia; results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
A Janssen-sponsored clinical trial evaluating antipsychotic treatment in community behavioral health organizations for schizophrenia and bip…
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia [Phase 2]
A Phase 2 trial evaluating galantamine in combination with CDP-choline for schizophrenia has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: General Practice Research Database Seroquel XR Safety Study
A completed safety study evaluating quetiapine extended-release (Seroquel XR) in patients with schizophrenia, major depressive disorder, and…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004) [Phase 2]
Phase 2 trial of MK-8998 in acutely psychotic participants with schizophrenia has completed, and results were posted in 2014. Sponsor: Merck…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Phase 4]
Phase 4 trial evaluating the efficacy, safety and tolerability of flexibly dosed paliperidone extended-release in adults with schizophrenia;…